Document Detail


The burden of liver disease in Europe: A review of available epidemiological data.
MedLine Citation:
PMID:  23419824     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
To survey the burden of liver disease in Europe and its causes 260 epidemiological studies published in the last five years were reviewed. The incidence and prevalence of cirrhosis and primary liver cancer are key to understand the burden of liver disease. They represent the end-stage of liver pathology and thus are indicative of the associated mortality. About 0.1% of Hungarian males will die of cirrhosis every year compared with 0.001% of Greek females. WHO estimate that liver cancer is responsible for around 47,000 deaths per year in the EU. Harmful alcohol consumption, viral hepatitis B and C and metabolic syndromes related to overweight and obesity are the leading causes of cirrhosis and primary liver cancer in Europe. Chronic hepatitis B affects 0.5-0.7% of the European population. In the last decade the prevalence of chronic hepatitis C was 0.13-3.26%. It is of great concern that about 90% of people in Europe infected by viral hepatitis are unaware of their status. Available data suggest the prevalence rate of NAFLD is 2-44% in the general European population (including obese children) and 42.6-69.5% in people with type 2 diabetes. Each of these four major causes of liver disease is amenable to prevention and treatment, reducing the burden of liver disease in Europe and saving lives. Further surveys are urgently needed to implement cost-effective prevention programmes and novel treatments to tackle this problem.
Authors:
Martin Blachier; Henri Leleu; Markus Peck-Radosavljevic; Dominique-Charles Valla; Françoise Roudot-Thoraval
Related Documents :
786214 - Hepatic granulomas in leprosy. their relation to bacteremia.
23526114 - Sexually transmitted infections and sexual function in relation to male fertility.
1597354 - Immunoreactivity of a mammalian liver component with leprosy sera.
22713254 - Effective hiv prevention: the indispensable role of social science.
24782264 - Case report of successful treatment of fibrosing cholestatic hepatitis c with sofosbuvi...
21050234 - Serum hbsag quantification to predict response to peginterferon therapy of e antigen po...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of hepatology     Volume:  58     ISSN:  1600-0641     ISO Abbreviation:  J. Hepatol.     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-02-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8503886     Medline TA:  J Hepatol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  593-608     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Affiliation:
Department of Public Health, Hôpital Henri Mondor, Université Paris-Est Créteil, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  DNA prime-protein boost vaccination enhances protective immunity against infectious bursal disease v...
Next Document:  A simple, rapid and inexpensive screening method for the identification of Pythium insidiosum.